Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer.
Schabath MB, Dalvi TB, Dai HA, Crim AL, Midha A, Shire N, Gimbrone NT, Walker J, Greenawalt DM, Lawrence D, Rigas JR, Brody R, Potter D, Kumar NS, Huntsman SA, Gray JE. Schabath MB, et al. Among authors: rigas jr. Cancer Manag Res. 2019 Nov 7;11:9469-9481. doi: 10.2147/CMAR.S218635. eCollection 2019. Cancer Manag Res. 2019. PMID: 31819612 Free PMC article.
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark.
Hedgeman E, Nørgaard M, Dalvi T, Pedersen L, Hansen HP, Walker J, Midha A, Shire N, Boothman AM, Fryzek JP, Rigas J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Cronin-Fenton D. Hedgeman E, et al. Cancer Epidemiol. 2021 Aug;73:101976. doi: 10.1016/j.canep.2021.101976. Epub 2021 Jul 1. Cancer Epidemiol. 2021. PMID: 34217914
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
Dalvi T, Nørgaard M, Fryzek JP, Movva N, Pedersen L, Pham Hansen H, Walker J, Midha A, Shire N, Boothman AM, Rigas J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Cronin-Fenton D. Dalvi T, et al. PLoS One. 2023 Apr 11;18(4):e0284037. doi: 10.1371/journal.pone.0284037. eCollection 2023. PLoS One. 2023. PMID: 37040387 Free PMC article.
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
Nayak L, DeAngelis LM, Robins HI, Govindan R, Gadgeel S, Kelly K, Rigas JR, Peereboom DM, Rosenfeld SS, Muzikansky A, Zheng M, Urban P, Abrey LE, Omuro A, Wen PY. Nayak L, et al. Among authors: rigas jr. Cancer. 2015 Dec 1;121(23):4165-72. doi: 10.1002/cncr.29636. Epub 2015 Aug 26. Cancer. 2015. PMID: 26308485 Free PMC article. Clinical Trial.
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.
Roengvoraphoj M, Tsongalis GJ, Dragnev KH, Rigas JR. Roengvoraphoj M, et al. Among authors: rigas jr. Cancer Treat Rev. 2013 Dec;39(8):839-50. doi: 10.1016/j.ctrv.2013.05.001. Epub 2013 Jun 12. Cancer Treat Rev. 2013. PMID: 23768755 Free article. Review.
96 results